Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
Sort by
Sort ascending
Study title
Condition
Phase
Location
NCT ID
Study title
Condition
Phase
Location
NCT ID
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Breast Neoplasms
Austria Germany
NCT06830720
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
Dengue
Phase2
Brazil Colombia IndiaMalaysia Singapore Vietnam
View all
NCT06006559
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prostate Cancer
Phase2, Phase3
Australia Brazil ChinaHong Kong Israel Japan Malaysia Singapore South Korea Switzerland Taiwan United States
View all
NCT06780670
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
Progressive Multiple Sclerosis
Phase1, Phase2
Australia Canada FranceGermany Italy Spain Switzerland
View all
NCT06675864
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase1, Phase2
France Japan United KingdomUnited States
View all
NCT06704269
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Relapsing Multiple Sclerosis (RMS)
Greece
NCT06486779
Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)
Pediatric Chronic Heart Failure
Japan
NCT06659393
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia - Heterozygous
Phase3
Argentina Austria BelgiumBrazil China Czechia France Germany Greece Hong Kong Hungary Israel Italy Malaysia Netherlands Poland Portugal South Africa Spain Taiwan Turkey (Türkiye) United Kingdom United States
View all
NCT06597019
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
Relapsing Multiple Sclerosis
Phase1, Phase2
Australia France GermanyItaly Spain Switzerland
View all
NCT06617793
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Relapsing Remitting Multiple Sclerosis (RRMS)
Phase4
Canada
NCT06733922
No matching countries found
Search